title: Uremia enhances the blood pressure response to erythropoietin.
abstract: To investigate the role of uremia in the development of human recombinant erythropoietin (r-HuEPO)-induced hypertension, Wistar rats were divided into a uremic (subtotal nephrectomy) and a control group. After three weeks, both groups were again divided and each subgroup received either r-HuEPO (100 u/kg s.c., 3 times weekly) or the vehicle for a further 3 weeks. Hematocrit, blood pressure and blood chemistry were measured prior to surgery, before either vehicle or r-HuEPO treatment and before euthanasia. The uremic group developed anemia, hypertension and all the biochemical features observed in humans with end-stage renal disease. r-HuEPO therapy increased hematocrit from 29 +/- 2.5% to 46 +/- 2% (p < 0.01) in the uremic rats. The mean baseline blood pressure was 119 +/- 10 mmHg. At week 3, mean blood pressure was unchanged in control rats, but it was increased to 151 +/- 5 mmHg (p < 0.01) in the nephrectomized group. At week 6, mean blood pressure in the untreated uremic rats remained unchanged from week 3, but blood pressure in the uremic animals treated with r-HuEPO increased significantly to 187 +/- 8 mmHg (p < 0.01). There was no significant correlation between hematocrit and blood pressure in the r-HuEPO treated uremic group (r = 0.01, NS). r-HuEPO had no effect on blood pressure in control rats despite a significant increase in hematocrit. These results indicate that the blood pressure response to r-HuEPO is enhanced in rats with chronic renal failure.
authors.affiliation: Department of Nephrology and Reseach Centre, L'Hôtel-Dieu de Québec Hospital, P.Q., Canada.
authors.forename: S
authors.initials: S
authors.lastname: Lacasse-M
authors.forename: I
authors.initials: I
authors.lastname: Kingma
authors.forename: R
authors.initials: R
authors.lastname: Larivière
authors.forename: J H
authors.initials: JH
authors.lastname: Grose
authors.forename: M
authors.initials: M
authors.lastname: Lebel
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003404:Creatinine / Q000097:blood; D004921:Erythropoietin / Q000494:pharmacology*; D006400:Hematocrit; D006801:Humans; D008297:Male; D009392:Nephrectomy; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins; D012016:Reference Values; D013599:Systole; D014511:Uremia / Q000097:blood / Q000503:physiopathology*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D003404:Creatinine